Obeticholic Acid Global Price Overview

Obeticholic acid is an agonist of the farnesoid X receptor (FXR) manufactured byIntercept Pharmaceuticals, Inc. The drug has been approved by the FDA (U.S. Food and Drug Administration) as a prescription drug specifically for the treatment of primary cholangitis. Obeticholic acid is currently receiving widespread attention around the world. However, as it has not yet been approved by the China Food and Drug Administration, domestic patients need to purchase and use it through overseas channels.

The selling price of original medicines is generally high, with the price of a box ranging from several thousand to tens of thousands of yuan, which is undoubtedly a heavy burden for many patient families. Fortunately, however, there are several generic versions of obeticholic acid on the market, providing patients with more options.

The generic version of obeticholic acid produced by Mylan Pharmaceuticals in India is very popular. The specification of this medicine is 10mg*100 tablets, and the price is less than 1,000 yuan. Compared with the original drug, the price is more affordable. It has become the first choice of many patients due to its high quality and reasonable price.

The Laos-ASEAN version of obeticholic acid generics also attracts the attention of patients. This medicine is available in two specifications: 5mg*30 tablets and 10mg*30 tablets, with prices ranging from a few hundred to more than a thousand yuan. Although the specific price changes depending on the specifications selected by the patient and regional differences, overall, the price is still relatively reasonable.

In addition, in Bangladesh, Beacon Pharmaceutical has launched a generic version of obeticholic acid. The specification of this medicine is 5mg*30 tablets. The price is slightly higher than the previous two versions, but it is still much cheaper than the original drug. The price of a box of 5mg*30 tablets is roughly more than 1,000 yuan, providing patients with another economical treatment option.

In summary, the emergence of obeticholic acid generics has brought more treatment options to patients while reducing their financial burden. It is hoped that more high-quality and economical drugs will be available in the future, bringing treatment hope to more patients.